Browsing category:

Antihyperphosphatemic


Sevelamer Hydrochloride, CAS number 152751-57-0 is efficacious when used to treat patients with kidney disease who are on dialysis. As patients with kidney disease have low blood levels of phosphorus, sevelamer binds with phosphorus in patients’ everyday diet, and prevents it from being absorbed into the blood stream. In capsule form, sevelamer is typically taken[…]

Read More

LGM Pharma Acquires CDMO

On July 27, 2020, LGM Pharma announced its acquisition of the formulation development and drug product contract manufacturing business of Nexgen Pharma, Inc. As a result, you will notice our new logo and visuals throughout the website. We’re working on updates to reflect the exciting, expanded CDMO capabilities and services we now can offer you.

This website uses cookies. By using our site, you agree to our terms of service